Mercado de vacunas de origen vegetal: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00024327
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 243
Buy Now

[Informe de investigación] Se espera que el mercado de vacunas de origen vegetal alcance los 2.672,05 millones de dólares en 2028, desde los 1.143,72 millones de dólares en 2021. Se estima que el mercado crecerá a una tasa compuesta anual del 12,9 % de 2021 a 2028.

El alcance del mercado de vacunas de origen vegetal incluye el tipo, la fuente, la aplicación y la geografía de la vacuna. Según la región, el mercado de vacunas de origen vegetal está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de vacunas a base de plantas, enfatizando varios parámetros como las tendencias y oportunidades del mercado, la dinámica del mercado y el análisis del panorama competitivo de los principales actores del mercado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. ; África y América del Sur y Central. También incluye análisis de impacto de COVID-19 en todas las regiones.


Perspectivas estratégicas

regiones lucrativas para el mercado de vacunas de origen vegetal


Perspectivas del mercado

Número cada vez mayor de investigaciones y análisis Actividades de desarrollo (I+D) de vacunas de origen vegetal

La falta de vacunas para prevenir enfermedades mortales ha creado problemas y ha provocado un enfoque mundial en el desarrollo de vacunas más seguras, fáciles y eficaces. Las plantas se encuentran entre los creadores de proteínas más prolíficos del mundo. Las plantas expresan eficientemente proteínas de diversa complejidad y patrones de glicosilación. La tecnología recombinante se utiliza para crear vacunas de origen vegetal, en las que el gen que codifica la proteína antigénica necesaria se incorpora al genoma de la planta. Además, los expertos estiman que la producción de una vacuna a base de plantas lleva de cinco a seis semanas en lugar de los cinco a seis meses que necesitan los fabricantes de vacunas para preparar la vacuna en huevos de gallina. Muchos países de todo el mundo están desarrollando una vacuna eficaz para combatir la propagación de la COVID-19, y las vacunas de origen vegetal son una de las opciones para el desarrollo de vacunas. Las vacunas de origen vegetal gozan de buena reputación entre los investigadores debido a su conocido procedimiento de fabricación exitoso y su bajo costo. Se llevan a cabo diversas investigaciones y ensayos clínicos para el desarrollo de vacunas de origen vegetal. Por ejemplo, Medicago Inc., una empresa de biotecnología en etapa clínica que utiliza tecnologías basadas en plantas para desarrollar y producir nuevas vacunas y anticuerpos, había producido con éxito partículas similares a virus (VLP) del nuevo coronavirus solo 20 días después de obtener la vacuna SARS-CoV. 2 gen (el virus que causa la enfermedad COVID-19). Los actores destacados existentes y los nuevos participantes en el mercado de vacunas de origen vegetal están concentrando sus esfuerzos en realizar ensayos clínicos integrales para producir vacunas de origen vegetal para una variedad de aplicaciones terapéuticas. De ahí que el creciente número de proyectos de investigación y de investigación. Las actividades de desarrollo (I+D) de vacunas de origen vegetal aumentarán sustancialmente la demanda de vacunas de origen vegetal en todo el mundo, lo que provocará un impulso al alza en el crecimiento del mercado.

< h3>Información basada en el tipo de vacuna

Según el tipo de vacuna, el mercado de vacunas de origen vegetal se segmenta en vacunas bacterianas, vacunas virales, vacunas parasitarias, partículas similares a virus derivadas de plantas (VLPS) y otras. . El segmento de vacunas bacterianas tuvo la mayor participación del mercado en 2021. Sin embargo, se anticipa que el segmento de partículas similares a virus de origen vegetal (VLP) registre la CAGR más alta del mercado del 13,6 % durante el período de pronóstico.

Mercado de vacunas de origen vegetal, por tipo de vacuna: 2021 y 2021 2028


Información basada en fuentes

Según la fuente, El mercado de vacunas de origen vegetal se segmenta en tabaco, maíz, patata y otros. El segmento de plantas de tabaco tuvo la mayor participación del mercado en 2021, y se anticipa que el mismo segmento registre la CAGR más alta del 13,3% en el mercado durante el período de pronóstico.

< h3>Información basada en aplicaciones

Según la aplicación, el mercado de vacunas de origen vegetal se segmenta en influenza, virus zika, virus del Ébola, enfermedades avícolas, COVID-19 y otros. El segmento de influenza tuvo la mayor participación del mercado en 2021. Sin embargo, se anticipa que el segmento de COVID-19 registre la CAGR más alta del mercado del 13,8% durante el período de pronóstico.

 

Las empresas suelen adoptar estrategias inorgánicas, como fusiones y adquisiciones, para satisfacer la demanda cambiante de los clientes y mantener su marca en todo el mundo. Los actores del mercado que operan en el mercado de vacunas de origen vegetal también adoptan estrategias orgánicas, como el lanzamiento y la expansión de productos, para ampliar su presencia y cartera de productos en todo el mundo y satisfacer la creciente demanda.

Por tipo de vacuna

  • Vacunas bacterianas
  • Vacunas virales
  • Vacunas parasitarias
  • Partículas similares a virus (VLP) de origen vegetal
  • Otros

Por fuente

  • Planta de tabaco
  • Maíz
  • Patata
  • Otros

Por aplicación

  • Influenza< /li>
  • Virus Zika
  • Virus Ébola
  • COVID-19
  • Enfermedades avícolas
  • Otras
  • Por geografía

    • América del Norte
      • Estados Unidos
      • Canadá
      • México
    • Europa
      • Reino Unido
      • Alemania
      • Francia
      • Italia
      • España
      • Resto de Europa
    • Asia Pacífico
      • China
      • Japón
      • India
      • Australia
      • Corea del Sur
      • Resto de Asia Pacífico
    • Medio Este y África
      • Arabia Saudita
      • Sudáfrica
      • EAU
      • Resto de Medio Oriente y África África
    • América del Sur y Central
      • Brasil
      • Argentina
      • Resto de América del Sur y Central

    Perfiles de la empresa

    • MEDICAGO, INC.
    • Británica American Tobacco plc
    • ICON GENETICS GMBH
    • CREATIVE BIOLABS, INC.                        
    • iBio, Inc.
    • LENIOBIO
    • Lumen Bioscience, Inc.
    • LEAF EXPRESSION SYSTEMS LTD.
    • ZYUS LIFE SCIENCES INC.
    • FRAUNHOFER CMB
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which source is expected to dominate the market in the forecast period in Plant-Based Vaccines market?

The market is led by source tobacco plant segment is growing significantly due to the increasing use of tobacco plants in pharmaceuticals. The growing research in pharmaceutical is playing a vital role in developing new vaccines. For instance the U.S Department of Agriculture approved a plant-based vaccine for Newcastle disease that infected poultry and produced it in suspension-cultured tobacco cells.

What will be the CAGR of Plant-Based Vaccines market?

The market is estimated to grow with a CAGR of 12.9% from 2021 to 2028.

What are the driving factors for the Plant-based Vaccines market across the globe?

Key factors that are driving growth of the market are increasing number of research & development (R&D) activities in plant-based vaccines and growing prevalence of infectious diseases market fuel the growth of the market.

What are Plant-Based Vaccines?

Plant-based vaccines can be made cheaply and produced on a large scale. These vaccines have several advantages, including being readily accepted by patients and stable for long-term antigen storage. These also help to reduce the economic burden of infectious disease globally. Various plants have developed plant-derived vaccines such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut. The choice of the plant depends on the route of administration of the vaccine.

The List of Companies - Plant-based Vaccines Market

  1. MEDICAGO, INC.
  2. British American Tobacco p.l.c.          
  3. ICON GENETICS GMBH
  4. CREATIVE BIOLABS, INC.      
  5. iBio, Inc.
  6. LENIOBIO
  7. Lumen Bioscience, Inc.
  8. LEAF EXPRESSION SYSTEMS LTD.
  9. ZYUS LIFE SCIENCES INC.
  10. FRAUNHOFER CMB

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports